how many glp-1 agonists are there Receptor as Treatments for Type 2 Diabetes GLP-1 Agonists - FAQ —
Description
Collins FW et al
Even knowing all the issues that surround this disease, unfortunately, obesity continues to grow
The half-life of oral semaglutide is approximately 1 week, aligning with subcutaneously administered form (102)
Without confirming functional outcomes at the tissue or organism level
Retatrutide (Eli Lilly), a triagonist currently in phase III clinical trials (TRIUMPH-1 NCT05929066 and others 3 ) adds a glucagon receptor agonist to its mechanism of action, promising an even greater impact on weight loss
Evidence for a direct mechanism is limited and will be more thoroughly examined in the mechanistic REMODEL trial (NCT04865770)
